Leukemia symptoms include fatigue, weakness, chest pain, shortness of breath, bleeding, bruising, and increased infection risk due to altered blood cell counts. Recent leukemia treatment advancements ...

Scientists at the University of Duisburg-Essen are researching new therapies for aggressive forms of childhood leukemia.

Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across ...

Leukemia is a blood cancer with abnormal white blood cell overproduction, affecting red blood cells and platelets, leading to anemia and infection risks. Diagnosis involves blood tests, bone marrow ...

The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...

WICHITA, Kan. (KWCH) - Kansas children battling leukemia have a new hope for survival thanks to a new treatment available in Wichita. KU School of Medicine-Wichita Doctors Nathan Hall and Brian Pate ...

The FDA has approved the CytoCell KMT2A Breakapart FISH Probe Kit PDx as a companion diagnostic (CDx) to accompany revumenib (Revuforj), a first-in-class Menin inhibitor for the treatment of relapsed ...

Preclinical data support SLS009 as a monotherapy or in combination with venetoclax for the treatment of T-PLL, a rare and highly aggressive form of mature T-cell leukemia NEW YORK, (GLOBE NEWSWIRE) -- ...

Asking about someone’s age is a well-known taboo. Unless, of course, you are asking a child. Then the topic of age is one that frequently brings joy and a sense of pride with each passing year. In ...